Who is sponsoring NCT03412227?

NCT03412227 is sponsored by Rutgers University.

What drugs are being tested in NCT03412227?

Interventions in NCT03412227: Individual Behavioral Activation Therapy (IBAT), The PASCET Program for Youth Depressive Disorders, The Coping Cat Program for Youth Anxiety Disorders, 14-week waitlist (WL) condition.

What condition does NCT03412227 study?

NCT03412227 studies Anxiety Disorders, Depression.

Is NCT03412227 still recruiting?

NCT03412227 is currently status unknown. Last updated 18 November 2023.

Last reviewed 2023-11-18 · How we verify

NCT03412227

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transdiagnostic Individual Behavioral Activation and Exposure Therapy

Status unknown NA Last updated 18 November 2023

What this trial tests

NA trial testing Individual Behavioral Activation Therapy (IBAT) in Anxiety Disorders in 200 participants. Status unknown.

Timeline

1 February 2018

Primary endpoint
31 August 2024

31 August 2025

Quick facts

Lead sponsor	Rutgers University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	200
Start date	1 February 2018
Primary completion	31 August 2024
Estimated completion	31 August 2025
Sites	1 location across United States

Drugs / interventions tested

Individual Behavioral Activation Therapy (IBAT)
The PASCET Program for Youth Depressive Disorders
The Coping Cat Program for Youth Anxiety Disorders
14-week waitlist (WL) condition

Conditions studied

Anxiety Disorders — all drugs for Anxiety Disorders →
Depression — all drugs for Depression →

Sponsor

Rutgers University

Who can join

Adults 9 to 17, any sex, with Anxiety Disorders or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Overall Aim of the this project is to compare treatment outcomes and change in putative treatment mediators in Individual Behavioral Activation Therapy (IBAT) against two active psychological interventions (Coping Cat, PASCET) and a wait-list control. Participants will be 200 youth (ages 9-17) diagnosed with a principal anxiety or depression disorder and their caregivers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Cognitive behavioural therapy for anxiety disorders in children and adolescents.
James AC, Reardon T, Soler A, James G, et al · · 2020 · cited 150× · PMID 33196111 · DOI 10.1002/14651858.cd013162.pub2

Verify or expand the search:

Other recruiting trials for Anxiety Disorders

Currently open trials in the same condition.

NCT07340281 — Biomarkers for Exercise · NA · recruiting
NCT07432945 — In Vivo Exposure vs. Videochat-Based Vicarious Exposure · NA · recruiting
NCT07316374 — AI Chatbots for Anxiety Mental Health Literacy · NA · active not recruiting
NCT07123467 — Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder · Phase 3 · recruiting
NCT07174947 — SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depre · Phase 2 · recruiting

Other Rutgers University trials

Trials by the same sponsor.

NCT04868123 — Effects of TENS and Mindfulness Meditation in Persons With HIV-related Neuropathy · NA · completed
NCT04563728 — Use Surveillance Technology to Reduce Elder Abuse Recidivism · NA · terminated
NCT04432493 — Using Combined EEG and Non-invasive Brain Stimulation to Examine and Improve Reward Functioning in Opioid Use Disorder · NA · completed
NCT04107688 — Taste Perception, Salivary Proteins & the Oral Microbiome · NA · completed
NCT03672266 — Studies of Brain and Body Interaction · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03412227 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rutgers University
Last refreshed: 18 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03412227.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing